MPEP § 2414.06 — Amendment of a “Sequence Listing XML” in a Patent (Annotated Rules)
§2414.06 Amendment of a “Sequence Listing XML” in a Patent
This page consolidates and annotates all enforceable requirements under MPEP § 2414.06, including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
Amendment of a “Sequence Listing XML” in a Patent
This section addresses Amendment of a “Sequence Listing XML” in a Patent. Primary authority: 37 CFR 1.835. Contains: 1 requirement.
Key Rules
Sequence Listing Content
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
Column and Line References
(f) Any appropriate amendments to the “Sequence Listing XML” in a patent (e.g., by reason of reissue, reexamination, or certificate of correction) must comply with the requirements of paragraph (b) of this section.
Sequence Listing Format
Where an amendment is made to a “Sequence Listing XML” contained in a patent, the correction must be made by way of an amendment to the “Sequence Listing XML” contained in a patent, pursuant to 1.835(b).
Citations
| Primary topic | Citation |
|---|---|
| Sequence Listing Content | 37 CFR § 1.831(b) |
Source Text from USPTO’s MPEP
This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.
Official MPEP § 2414.06 — Amendment of a “Sequence Listing XML” in a Patent
Source: USPTO2414.06 Amendment of a “Sequence Listing XML” in a Patent [R-01.2024]
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
37 CFR 1.835 Amendment to add or replace a “Sequence Listing XML” in patent applications filed on or after July 1, 2022.
-
*****
- (f) Any appropriate amendments to the “Sequence Listing XML” in a patent (e.g., by reason of reissue, reexamination, or certificate of correction) must comply with the requirements of paragraph (b) of this section.
Where an amendment is made to a “Sequence Listing XML” contained in a patent, the correction must be made by way of an amendment to the “Sequence Listing XML” contained in a patent, pursuant to 1.835(b).